Sunitinib Renal Cell Carcinoma
Links shared publicly online about this topic
Papillary Renal Cell Carcinoma Unresponsive To Sunitinib
medicalnewstoday.com — “Of the more than 38,000 Americans diagnosed with renal cell carcinoma (RCC) each year, approximately 20 percent have non-clear cell forms of the disease. New findings shows that a non-clear cell f” View full resource at medicalnewstoday.com
Most Recently Shared on June 1, 2010 at 12:07 pm By:
Papillary Renal Cell Carcinoma Unresponsive To Sunitinib http://mnt.to/3Djg #cancer
Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
jnci.oxfordjournals.org — “Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib” View full resource at jnci.oxfordjournals.org
Most Recently Shared on May 5, 2011 at 2:00 am By:
Michael Fisch Physician, Doctor, Internist, Pain Medicine Physician, and Oncologist
Hypertension as biomarker for treatment efficacy? JNCI: sunitinib data in renal cell #cancer, http://ow.ly/4Nukp, #cardiac #heart
Researchers Find Papillary Renal Cell Carcinoma Unresponsive to Sunitinib
fccc.edu — “Researchers Find Papillary Renal Cell Carcinoma Unresponsive to Sunitinib” View full resource at fccc.edu
Most Recently Shared on June 5, 2010 at 3:35 am By:
Kidney Cancer Health Executive
Researchers Find Papillary Renal Cell Carcinoma Unresponsive to Sunitinib http://bit.ly/9Vx44I
Toxicity of Sunitinib Plus Bevacizumab in Renal Cell Carcinoma --" JCO
jco.ascopubs.org — “Toxicity of Sunitinib Plus Bevacizumab in Renal Cell Carcinoma --" JCO” View full resource at jco.ascopubs.org
Most Recently Shared on June 9, 2010 at 4:59 pm By:
Kidney Cancer Health Executive
Toxicity of Sunitinib Plus Bevacizumab in Renal Cell Carcinoma http://bit.ly/bjgaQW
Researchers find papillary renal cell carcinoma unresponsive to sunitinib
physorg.com — “Of the more than 38,000 Americans diagnosed with renal cell carcinoma (RCC) each year, approximately 20 percent have non-clear cell forms of the disease. New findings shows that a non-clear cell form of kidney cancer known as papillary RCC, which accounts for 12 percent of all RCC, responds differently ...” View full resource at physorg.com
Most Recently Shared on May 28, 2010 at 9:37 pm By:
PhysOrg Health News Health News
Researchers find papillary renal cell carcinoma unresponsive to sunitinib http://tw.physorg.com/194286214
Oncology Article | Carcinoma, Renal Cell
mdlinx.com — “Sunitinib in Metastatic Renal Cell Carcinoma: Recommendations for Management of Noncardiovascular Toxicities” View full resource at mdlinx.com
Most Recently Shared on May 23, 2011 at 4:39 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Sunitinib in Metastatic Renal Cell Carcinoma: Recommendations for Management of Noncardiovascular Toxi... http://bit.ly/m800vo #oncology
Nephrology Article | renal cell carcinoma
mdlinx.com — “Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma” View full resource at mdlinx.com
Most Recently Shared on July 29, 2011 at 4:46 pm By:
Kidney Cancer Health Executive
Complete response to sunitinib in a patient with relapsed irresectable renal cell carcinoma http://bit.ly/qAP8yc
Oncology Article | Carcinoma Carcinoma, Renal Cell
mdlinx.com — “Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma” View full resource at mdlinx.com
Most Recently Shared on September 7, 2011 at 8:32 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase 1 trial of everolimus plus sunitinib in patients with metastatic renal cell carcinoma: Cancer http://t.co/ZVbjdFN #oncology
Oncology Article | Carcinoma Carcinoma, Renal Cell
mdlinx.com — “Sequential treatment with sorafenib and sunitinib in metastatic renal cell carcinoma: Clinical outcomes from a retrospective clinical study” View full resource at mdlinx.com
Most Recently Shared on February 11, 2011 at 5:29 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Sequential treatment with sorafenib and sunitinib in metastatic renal cell carcinoma: Clinical outcome... http://bit.ly/ffZp6Q #oncology
Oncology Article | Carcinoma, Renal Cell
mdlinx.com — “Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination” View full resource at mdlinx.com
Most Recently Shared on May 27, 2011 at 10:27 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cel... http://bit.ly/iWFPxO #oncology
Oncology Article | renal cell carcinoma
mdlinx.com — “Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma” View full resource at mdlinx.com
Most Recently Shared on June 10, 2011 at 3:17 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Could thyroid dysfunction influence outcome in sunitinib-treated metastatic renal cell carcinoma: Anna... http://bit.ly/lHQ9Ml #oncology
Oncology Article | Renal cell carcinoma
mdlinx.com — “The incidence and mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma” View full resource at mdlinx.com
Most Recently Shared on January 3, 2011 at 8:19 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The incidence and mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cel... http://bit.ly/e6pJU4 #oncology
Oncology Article | renal cell carcinoma
mdlinx.com — “Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with metastatic renal cell carcinoma” View full resource at mdlinx.com
Most Recently Shared on September 8, 2011 at 3:10 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Phase II trial of continuous once-daily dosing of sunitinib as first-line treatment in patients with m... http://t.co/fh0fGXX #oncology
Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib
annonc.oxfordjournals.org — “Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib” View full resource at annonc.oxfordjournals.org
Most Recently Shared on April 18, 2011 at 10:12 pm By:
Symposier Nephrology Health Business and Nephrology
Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib. http://bit.ly/hHDYQX
Oncology Article | renal Cell Carcinoma
mdlinx.com — “Incidence and Risk of Congestive Heart Failure in Patients With Renal and Nonrenal Cell Carcinoma Treated With Sunitinib” View full resource at mdlinx.com
Most Recently Shared on August 4, 2011 at 1:14 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Incidence and Risk of Congestive Heart Failure in Patients With Renal and Nonrenal Cell Carcinoma Trea... http://bit.ly/pEdV43 #oncology
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MNT Cancer News
The latest cancer news published daily. Articles from research centers, universities and prestigious journals.
-
Michael Fisch
Dept of General Oncology, M.D. Anderson Cancer Center. Tweeting on community/academic oncology, cancer symptoms and side effects, QOL, survivorship, and EOL.
-
Kidney Cancer
The world's oldest, largest, and most widely respected kidney cancer advocacy organization. Now serving 102 nations. Bill Bro, CEO.
Advertisement
